Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Kathrin DanningerCardiology Department Klinikum Wels-Grieskirchen Wels Austria.ORCID 0000-0001-9617-3034
Elpida AthanasopoulouCardiovascular Prevention and Research Unit, Clinic-Laboratory of Pathophysiology and First Department of Propeadeutic Internal Medicine, Laiko Hospital, Medical School National and Kapodistrian University of Athens Greece.ORCID 0009-0009-6272-7102
Mohsen AgharaziiDépartement de Médecine, Faculté de Médecine Université Laval Québec City QC Canada.ORCID 0000-0002-7628-5757
Antonios A ArgyrisCardiovascular Prevention and Research Unit, Clinic-Laboratory of Pathophysiology and First Department of Propeadeutic Internal Medicine, Laiko Hospital, Medical School National and Kapodistrian University of Athens Greece.ORCID 0000-0002-8906-6959
Sola Aoun BahousLebanese American University School of Medicine Byblos Lebanon.ORCID 0000-0002-7159-7559
Jose R BanegasDepartment of Preventive Medicine and Public Health, School of Medicine Universidad Autónoma de Madrid and CIBER in Epidemiology and Public Health (CIBERESP) Madrid Spain.ORCID 0000-0001-6152-9862
Ronald K BinderCardiology Department Klinikum Wels-Grieskirchen Wels Austria.ORCID 0000-0001-9985-3748
Jacques BlacherAP-HP-Centre Université Paris Cité, Hôpital Hôtel-Dieu, Centre de diagnostic et de thérapeutique Paris France.ORCID 0000-0003-4860-4279
Matthias C BrandtDepartment of Internal Medicine II Paracelsus Medical University Salzburg Austria.ORCID 0000-0002-8825-0770
Alejandro de la SierraInternal Medicine Department, Hospital Mutua Terrassa University of Barcelona Spain.ORCID 0000-0002-6548-5497
Eugenia Gkaliagkousi3rd Department of Internal Medicine Aristotle University of Thessaloniki Greece.ORCID 0000-0002-6324-2475
Cristina GiannattasioSchool of Medicine and Surgery Milano-Bicocca University and Cardiology 4, ASST GOM Niguarda Milan Italy.ORCID 0000-0001-9116-3494
Bernhard HametnerCenter for Health & Bioresources AIT Austrian Institute of Technology Vienna Austria.ORCID 0000-0003-2048-1019
Piotr JankowskiDepartment of Internal Medicine and Geriatric Cardiology Medical Centre of Postgraduate Education Warszawa Poland.ORCID 0000-0001-6223-8821
Anastasios KolliasHypertension Center STRIDE-7, School of Medicine National and Kapodistrian University of Athens, Third Department of Medicine, Sotiria Hospital Athens Greece.ORCID 0000-0002-2098-1665
Yan LiDepartment of Cardiovascular Medicine, Shanghai Institute of Hypertension, Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China.ORCID 0000-0002-5825-5968
Alessandro MalobertiSchool of Medicine and Surgery Milano-Bicocca University and Cardiology 4, ASST GOM Niguarda Milan Italy.ORCID 0000-0002-2612-6264
Christopher C MayerCenter for Health & Bioresources AIT Austrian Institute of Technology Vienna Austria.ORCID 0000-0002-5612-5481
Barry J McDonnellCentre for Cardiovascular Research, Innovation and Development, Cardiff School of Sport and Health Sciences Cardiff Metropolitan University Cardiff UK.ORCID 0000-0001-5912-1278
Carmel M McEnieryExperimental Medicine and Immunotherapeutics, Addenbrooke's Hospital University of Cambridge UK.ORCID 0000-0003-3636-0705
Fotis KarachaliasCardiovascular Prevention and Research Unit, Clinic-Laboratory of Pathophysiology and First Department of Propeadeutic Internal Medicine, Laiko Hospital, Medical School National and Kapodistrian University of Athens Greece.ORCID 0000-0003-0999-9765
Maria L MuiesanDepartment of Clinical and Experimental Sciences, Centro per la Prevenzione e Cura dell'ipertensione Arteriosa University of Brescia and ASST Spedali Civili Lombardy Italy.ORCID 0000-0002-4007-9441
Janos NemcsikDepartment of Family Medicine Semmelweis University Budapest Hungary.ORCID 0000-0002-3573-0287
Daniel PiskorzCardiovascular Research Center Rosario British Sanatorium Rosario Argentina.
Giacomo PucciUnit of Internal and Translational Medicine, Terni Hospital, Department of Medicine and Surgery University of Perugia Italy.ORCID 0000-0003-0180-859X
Enrique RodillaDepartment of Internal Medicine, Hypertension and Vascular Risk Unit Hospital de Sagunto Spain.ORCID 0000-0003-3669-4270
Petros P SfikakisCardiovascular Prevention and Research Unit, Clinic-Laboratory of Pathophysiology and First Department of Propeadeutic Internal Medicine, Laiko Hospital, Medical School National and Kapodistrian University of Athens Greece.
George S StergiouHypertension Center STRIDE-7, School of Medicine National and Kapodistrian University of Athens, Third Department of Medicine, Sotiria Hospital Athens Greece.ORCID 0000-0002-6132-0038
Dimitrios Terentes-PrintziosFirst Department of Cardiology, Hippokration Hospital, Medical School National and Kapodistrian University of Athens Greece.ORCID 0000-0003-4039-8263
Charalambos VlachopoulosFirst Department of Cardiology, Hippokration Hospital, Medical School National and Kapodistrian University of Athens Greece.ORCID 0000-0002-9904-3558
Ian WilkinsonExperimental Medicine and Immunotherapeutics, Addenbrooke's Hospital University of Cambridge UK.ORCID 0000-0001-6598-9399
Athanase D ProtogerouCardiovascular Prevention and Research Unit, Clinic-Laboratory of Pathophysiology and First Department of Propeadeutic Internal Medicine, Laiko Hospital, Medical School National and Kapodistrian University of Athens Greece.ORCID 0000-0002-3825-532X
James E SharmanMenzies Institute for Medical Research University of Tasmania Hobart Australia.ORCID 0000-0003-2792-0811
Siegfried WassertheurerCenter for Health & Bioresources AIT Austrian Institute of Technology Vienna Austria.ORCID 0000-0002-5599-9689
backgroundCentral systolic blood pressure (cSBP) reflects the pressure experienced by vital organs and may be more closely related to hypertensive cardiac damage than brachial SBP. Twenty-four-hour ambulatory blood pressure monitoring provides additional insight into cardiovascular load beyond office readings. This study investigated the association of 24-hour cSBP, measured noninvasively with a validated device, with left ventricular mass index (LVMi) and LV hypertrophy.
methodsWe analyzed data from 21 centers worldwide (n=2367; 45.5% women; mean age 49.5 years) participating in the International 24-Hour Aortic Blood Pressure Consortium. Brachial and central 24-hour SBPs were recorded using the Mobil-O-Graph device, calibrated by either systolic/diastolic (cSBP C1) or mean/diastolic (cSBP C2) pressure; LVMi was derived echocardiographically. BP phenotypes (normotension, isolated diastolic and systolic hypertension, and systolic-diastolic hypertension) were based on 24-hour brachial BPs, subdivided by cSBP.
resultsLVMi correlated most strongly with 24-hour cSBP C2 (
conclusionsTwenty-four-hour central SBP calibrated with oscillometric mean/diastolic pressure (cSBP C2), is more closely associated with LVMi and LV hypertrophy than brachial SBP. These findings highlight the potential clinical value of incorporating central pressure monitoring into risk assessment and hypertension management.
Indexed as
Arterial PressureBlood PressureBlood Pressure Monitoring, AmbulatoryHypertensionHypertrophy, Left VentricularVentricular Function, LeftAdultEchocardiographyFemaleHumansMaleMiddle AgedPredictive Value of TestsRisk FactorsROC CurveTime Factors24‐hour blood pressure monitoringcentral systolic blood pressureechocardiographyhypertrophy, left ventricularleft ventricular massmulticenter study
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Central Systolic Blood Pressure and Left Ventricular Mass: Findings From the International 24-Hour Aortic Blood Pressure Consortium. · full record | OpenQuestion